BPC-157 | TB-500
Tissue Repair Peptide Blend
Blend Components:
BPC-157
CAS: 137525-51-0
Formula: C62H98N16O22
M.W.: 1419.5347 g/mol
TB-500
CAS: 77591-33-4
Formula: C212H350N56O78S
M.W.: 4963.4421 g/mol
Purity: 99%+ HPLC Verified
Ref No.:BPT-0005VI
Ref No.:BPT-0010VI
For Research Use Only (RUO)
Not for human or veterinary use.
BPC-157 | TB-500 (Blend)
Category
Tissue Repair / Regenerative Research
Form Factor
Lyophilized Powder
Blend Components
BPC-157
CAS
137525-51-0
Formula
C62H98N16O22
Molar Mass
1419.5347 g/mol
TB-500
CAS
77591-33-4
Formula
C212H350N56O78S
Molar Mass
4963.4421 g/mol
BPC-157
5 mg
10 mg
CAS: 137525-51-0
TB-500
5 mg
10 mg
CAS: 77591-33-4
In stock, ready to ship
Ships same day before 12pm PST
Products are shipped in lyophilized powder form.
This blend combines two leading tissue-repair peptides: BPC-157 and TB-500. BPC-157 works through angiogenesis and growth factor upregulation, while TB-500 promotes repair via actin upregulation, cell migration, and anti-inflammatory signaling. Together they target complementary regenerative mechanisms.
Description
This blend combines two leading tissue-repair peptides: BPC-157 and TB-500. BPC-157 works through angiogenesis and growth factor upregulation, while TB-500 promotes repair via actin upregulation, cell migration, and anti-inflammatory signaling. Together they target complementary regenerative mechanisms.Chemical Information
Purity
99%+ HPLC Verified
Form Factor
Lyophilized Powder
Synonyms
Blend Components
BPC-157
CAS
137525-51-0
Formula
C62H98N16O22
Molar Mass
1419.5347 g/mol
TB-500
CAS
77591-33-4
Formula
C212H350N56O78S
Molar Mass
4963.4421 g/mol
BPC-157
5 mg
10 mg
CAS: 137525-51-0
TB-500
5 mg
10 mg
CAS: 77591-33-4
Research Applications
- Combination Peptide Therapy: The BPC-157 and TB-500 blend is studied for synergistic tissue repair mechanisms that exceed the effects of either peptide alone. BPC-157 promotes angiogenesis and growth factor upregulation while TB-500 drives cell migration via actin modulation. Research examines how these complementary mechanisms interact at the molecular level to produce accelerated healing in connective tissue, muscle, and joint injury models.
- Sports Medicine Research: This blend is investigated in sports science contexts for its potential to accelerate recovery from musculoskeletal injuries. Studies examine healing timelines for tendon, ligament, and muscle injuries when both peptides are co-administered, comparing outcomes against single-peptide protocols. The complementary mechanisms — vascular support (BPC-157) and cellular repair (TB-500) — provide a multi-target approach to athletic injury recovery research.
- Regenerative Medicine: In regenerative medicine, the BPC-157/TB-500 combination is studied for its ability to address multiple phases of wound healing simultaneously. BPC-157 supports the inflammatory resolution and angiogenic phases while TB-500 promotes the proliferative and remodeling phases. Research aims to optimize dosing ratios and timing to maximize the synergistic healing response across different tissue types.
- Pharmacology: This blend serves as a model system for studying peptide-peptide interactions and combinatorial pharmacodynamics. Research examines potential receptor cross-talk, shared signaling pathway modulation, and whether the two peptides exhibit additive, synergistic, or antagonistic effects across different tissues and injury models. These findings inform broader combination peptide therapy development.
Storage Conditions
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
Safety & Compliance
- Wear nitrile gloves and safety goggles when handling research compounds.
- Work in a clean, controlled environment (laminar flow hood recommended).
- Dispose of sharps and used materials in approved biohazard containers.
- This product is for laboratory research use only (RUO) — not for human or veterinary use.
Quality Assurance Standards
Each production lot is subjected to rigorous analytical evaluation to meet pharmaceutical-grade specifications. Full testing results and procedural documentation are furnished through the accompanying Certificate of Analysis (COA) with every shipment.
Certificate of Analysis
Latest COA for BPC-157 | TB-500 (Blend) — independently tested via HPLC and Mass Spectrometry.
Testing Methodology
Every batch undergoes a multi-stage analytical pipeline before release. Results are compiled into the Certificate of Analysis (COA) included with each order.
- • HPLC — High-Performance Liquid Chromatography confirms peptide purity ≥98%.
- • Mass Spectrometry — Validates molecular identity and correct sequence.
- • Endotoxin (LAL) — Limulus Amebocyte Lysate assay ensures endotoxin levels are within safe limits.
- • Sterility — Microbial contamination testing per USP standards.
Learn More About Peptides
Explore our research library covering purity, synthesis, storage, solubility, and more.
Research Database
Browse peer-reviewed studies, clinical trials, and scientific sources behind our peptide resources.
You May Also Like
Stacking Considerations
This classic healing blend combines two synergistic tissue-repair peptides.
-
$109.99
BPC-157 (Spray)
Tissue Repair / Regenerative Research View DetailsThis product has multiple variants. The options may be chosen on the product page -
$74.99
LL-37
GH / Neuro / Misc Research View DetailsThis product has multiple variants. The options may be chosen on the product page -
$99.99
NAD+ (Spray)
GH / Neuro / Misc Research View DetailsThis product has multiple variants. The options may be chosen on the product page -
$124.99
Semax (Spray)
GH / Neuro / Misc Research View DetailsThis product has multiple variants. The options may be chosen on the product page
Collagen remodeling & skin repair
Antimicrobial wound protection
Popular Product
Popular Product
Description
This blend combines two leading tissue-repair peptides: BPC-157 and TB-500. BPC-157 works through angiogenesis and growth factor upregulation, while TB-500 promotes repair via actin upregulation, cell migration, and anti-inflammatory signaling. Together they target complementary regenerative mechanisms.Chemical Information
Purity
99%+ HPLC Verified
Form Factor
Lyophilized Powder
Synonyms
Blend Components
BPC-157
CAS
137525-51-0
Formula
C62H98N16O22
Molar Mass
1419.5347 g/mol
TB-500
CAS
77591-33-4
Formula
C212H350N56O78S
Molar Mass
4963.4421 g/mol
BPC-157
5 mg
10 mg
CAS: 137525-51-0
TB-500
5 mg
10 mg
CAS: 77591-33-4
Research Applications
- Combination Peptide Therapy: The BPC-157 and TB-500 blend is studied for synergistic tissue repair mechanisms that exceed the effects of either peptide alone. BPC-157 promotes angiogenesis and growth factor upregulation while TB-500 drives cell migration via actin modulation. Research examines how these complementary mechanisms interact at the molecular level to produce accelerated healing in connective tissue, muscle, and joint injury models.
- Sports Medicine Research: This blend is investigated in sports science contexts for its potential to accelerate recovery from musculoskeletal injuries. Studies examine healing timelines for tendon, ligament, and muscle injuries when both peptides are co-administered, comparing outcomes against single-peptide protocols. The complementary mechanisms — vascular support (BPC-157) and cellular repair (TB-500) — provide a multi-target approach to athletic injury recovery research.
- Regenerative Medicine: In regenerative medicine, the BPC-157/TB-500 combination is studied for its ability to address multiple phases of wound healing simultaneously. BPC-157 supports the inflammatory resolution and angiogenic phases while TB-500 promotes the proliferative and remodeling phases. Research aims to optimize dosing ratios and timing to maximize the synergistic healing response across different tissue types.
- Pharmacology: This blend serves as a model system for studying peptide-peptide interactions and combinatorial pharmacodynamics. Research examines potential receptor cross-talk, shared signaling pathway modulation, and whether the two peptides exhibit additive, synergistic, or antagonistic effects across different tissues and injury models. These findings inform broader combination peptide therapy development.
Storage Conditions
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
Safety & Compliance
- Wear nitrile gloves and safety goggles when handling research compounds.
- Work in a clean, controlled environment (laminar flow hood recommended).
- Dispose of sharps and used materials in approved biohazard containers.
- This product is for laboratory research use only (RUO) — not for human or veterinary use.
Quality Assurance Standards
Each production lot is subjected to rigorous analytical evaluation to meet pharmaceutical-grade specifications. Full testing results and procedural documentation are furnished through the accompanying Certificate of Analysis (COA) with every shipment.
Certificate of Analysis
Latest COA for BPC-157 | TB-500 (Blend) — independently tested via HPLC and Mass Spectrometry.
Testing Methodology
Every batch undergoes a multi-stage analytical pipeline before release. Results are compiled into the Certificate of Analysis (COA) included with each order.
- • HPLC — High-Performance Liquid Chromatography confirms peptide purity ≥98%.
- • Mass Spectrometry — Validates molecular identity and correct sequence.
- • Endotoxin (LAL) — Limulus Amebocyte Lysate assay ensures endotoxin levels are within safe limits.
- • Sterility — Microbial contamination testing per USP standards.
Learn More About Peptides
Explore our research library covering purity, synthesis, storage, solubility, and more.
Research Database
Browse peer-reviewed studies, clinical trials, and scientific sources behind our peptide resources.
